Which of the following is NOT associated with AIDS?
Subacute sclerosing panencephalitis (SSPE) is a complication of which viral infection?
What is the most common cause of death in measles?
Herpes zoster most commonly involves which nerve division?
What is the drug of choice for acyclovir-resistant herpes simplex virus (HSV) or varicella-zoster virus (VZV) infections?
Herpes zoster infection can lead to which of the following complications?
Pneumocystis prophylaxis is indicated when the CD4 count is?
What is the causative agent of SARS?
Which viral infection is associated with neutropenia?
What is the marker test for vertical transmission of HIV?
Explanation: **Explanation:** In AIDS, the hallmark of the disease is the progressive depletion of CD4+ T-helper cells [1], leading to profound immune dysregulation. **Why Hypogammaglobulinemia is the Correct Answer:** Patients with AIDS typically exhibit **Hypergammaglobulinemia** (specifically polyclonal gammaglobulinemia), not hypogammaglobulinemia. This occurs because of chronic, non-specific B-cell activation. Although the B-cells are increased in number and produce high levels of immunoglobulins (IgG and IgA), they are functionally defective and fail to mount an effective antibody response to new antigens or vaccines. **Analysis of Incorrect Options:** * **A. Increased p24 antibody:** In the early stages of HIV infection (seroconversion), the body produces antibodies against the p24 capsid antigen [2]. While p24 *antigen* levels rise during acute infection and late-stage AIDS, p24 *antibodies* are characteristic of the asymptomatic phase. * **C. Abnormal mitogen assay:** Since T-cell function is severely compromised, there is a decreased proliferative response to mitogens (like Phytohemagglutinin/PHA). This is a classic laboratory finding in cellular immunodeficiency. * **D. Anergy:** This refers to the lack of a delayed-type hypersensitivity (DTH) response to common recall antigens (e.g., Tuberculin/PPD). It occurs due to the profound loss of effector T-cells [1]. **High-Yield NEET-PG Pearls:** * **CD4:CD8 Ratio:** In healthy individuals, the ratio is ~2:1. In AIDS, this ratio **inverts** to <1:1 [1]. * **B-cell paradox:** AIDS is characterized by high quantitative globulins but poor qualitative function (increased risk of infections by encapsulated bacteria like *S. pneumoniae*). * **Window Period:** The time between infection and the appearance of detectable antibodies (usually 2-12 weeks). The p24 antigen is the earliest marker detectable during this phase [2].
Explanation: **Explanation:** **Subacute Sclerosing Panencephalitis (SSPE)** is a rare, progressive, and fatal neurodegenerative disease caused by a persistent, aberrant infection of the central nervous system with a **mutated Measles virus**. [1] 1. **Why Measles is Correct:** SSPE occurs years (typically 5–10) after an initial measles infection, usually in children who contracted the virus before age two. [1] The underlying mechanism involves a **defective "M" (matrix) protein** of the measles virus, which prevents the virus from budding out of host cells. Instead, the virus spreads directly from cell to cell via syncytia formation, leading to widespread inflammation, demyelination, and neuronal death in both gray and white matter (hence "panencephalitis"). 2. **Why Other Options are Incorrect:** * **Rubella:** Associated with Progressive Rubella Panencephalitis (PRP), which clinically mimics SSPE but is caused by the Rubella virus. * **Mumps:** Commonly causes viral meningitis or acute encephalitis, but not a chronic sclerosing panencephalitis. * **Chickenpox (VZV):** Can cause acute cerebellar ataxia or encephalitis, and its reactivation leads to Herpes Zoster (shingles), but not SSPE. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Stages:** Characterized by behavioral changes (Stage 1), followed by pathognomonic **periodic myoclonic jerks** (Stage 2), and eventually dementia and akinetic mutism. * **EEG Finding:** Classic **periodic, high-voltage slow-wave complexes** (Radermecker complexes) synchronized with myoclonus. * **CSF Analysis:** Shows significantly **elevated anti-measles antibody titers** and oligoclonal bands (increased IgG). [2] * **Diagnosis:** Based on Dyken’s criteria. * **Prevention:** The most effective strategy is vaccination with the **MMR vaccine**. [1]
Explanation: **Explanation:** **Pneumonia** is the most common cause of death associated with measles in both children and adults. Measles virus causes profound transient immunosuppression by depleting T-lymphocytes and altering cytokine responses. This predisposes patients to secondary bacterial infections (most commonly *S. pneumoniae*, *H. influenzae*, and *S. aureus*) or primary viral giant cell pneumonia (Hecht’s pneumonia) [1]. While measles is often perceived as a simple rash, respiratory complications account for nearly 60% of measles-related mortality. **Analysis of Incorrect Options:** * **Encephalitis:** While Acute Disseminated Encephalomyelitis (ADEM) and Subacute Sclerosing Panencephalitis (SSPE) are severe neurological complications with high morbidity, they occur much less frequently than respiratory complications [1]. * **Meningitis:** Measles rarely presents as isolated meningitis; neurological involvement typically manifests as encephalitis or encephalopathy. * **Dehydration:** Although diarrhea is the most common *complication* of measles overall (especially in malnourished children), it is secondary to pneumonia as a cause of death in global statistics. **NEET-PG High-Yield Pearls:** * **Most common complication:** Diarrhea. * **Most common cause of death:** Pneumonia. * **Most common CNS complication:** Acute febrile encephalitis. * **Pathognomonic sign:** Koplik spots (found opposite the lower second molars) [1]. * **Vitamin Supplementation:** Vitamin A is crucial in management as it reduces the severity of complications and mortality risk [1]. * **SSPE:** A late, fatal neurodegenerative complication occurring years after the initial infection due to a persistent mutant virus [1].
Explanation: **Explanation:** Herpes Zoster (Shingles) results from the reactivation of the latent Varicella-Zoster Virus (VZV) within the sensory ganglia. While the virus most frequently affects the **thoracic dermatomes** (50–60% of cases) [1], the **Trigeminal nerve (Cranial Nerve V)** is the most common cranial nerve involved. Among the three branches of the Trigeminal nerve, the **Ophthalmic division (V1)** is most frequently affected, a condition known as *Herpes Zoster Ophthalmicus*. This occurs because the virus remains latent in the trigeminal ganglion and, upon reactivation, travels preferentially along the V1 fibers to the forehead and cornea. **Analysis of Options:** * **Option B (Correct):** The Ophthalmic division (V1) is the most common site for cranial zoster. Involvement of the nasociliary branch (indicated by vesicles on the tip of the nose—**Hutchinson’s sign**) is a strong predictor of ocular complications like keratitis. * **Options C & D (Incorrect):** The Maxillary (V2) and Mandibular (V3) divisions are significantly less common sites for reactivation compared to V1. * **Option A (Incorrect):** While the Facial nerve (CN VII) can be involved (leading to **Ramsay Hunt Syndrome** or Herpes Zoster Oticus), it is less frequent than Trigeminal involvement. **High-Yield Clinical Pearls for NEET-PG:** 1. **Most common site overall:** Thoracic dermatomes (T3 to L2) [1]. 2. **Hutchinson’s Sign:** Vesicles on the side or tip of the nose; indicates high risk of corneal involvement. 3. **Ramsay Hunt Syndrome:** Triad of ipsilateral facial paralysis, ear pain, and vesicles in the auditory canal (CN VII involvement). 4. **Post-herpetic Neuralgia (PHN):** The most common complication of Herpes Zoster, defined as pain persisting >90 days after the rash heals [1]. 5. **Treatment:** Oral Acyclovir, Valacyclovir, or Famciclovir (ideally started within 72 hours) [1].
Explanation: **Explanation:** The mechanism of resistance in HSV and VZV against Acyclovir most commonly involves a **mutation or deficiency in the viral enzyme Thymidine Kinase (TK)** [1]. Since Acyclovir requires TK for its initial phosphorylation to become active, TK-deficient strains are resistant to Acyclovir, Valacyclovir, and Famciclovir [1]. **1. Why Foscarnet is the Correct Answer:** Foscarnet is a pyrophosphate analog that **directly inhibits viral DNA polymerase** without requiring activation (phosphorylation) by viral Thymidine Kinase. Therefore, it remains highly effective against TK-deficient, acyclovir-resistant strains of HSV and VZV. **2. Analysis of Incorrect Options:** * **Valacyclovir (Option C) & Famciclovir (Option D):** These are prodrugs of Acyclovir and Penciclovir, respectively. Like Acyclovir, they require viral Thymidine Kinase for activation [1]. If a virus is resistant to Acyclovir due to a TK mutation, it will show cross-resistance to these drugs [1]. * **Cidofovir (Option B):** While Cidofovir also bypasses the need for viral TK (it is a nucleotide analog), it is generally considered a **second-line** alternative to Foscarnet for acyclovir-resistant HSV due to its significant nephrotoxicity and lower clinical preference in this specific scenario. **Clinical Pearls for NEET-PG:** * **Mechanism of Foscarnet:** Non-competitive inhibition of RNA and DNA polymerase (binds to the pyrophosphate binding site). * **Major Side Effect of Foscarnet:** Nephrotoxicity and electrolyte imbalances (hypocalcemia, hypomagnesemia, and hypokalemia). It can also cause genital ulcerations. * **Drug of Choice for CMV Retinitis:** Ganciclovir (Foscarnet is used if Ganciclovir resistance develops). * **Acyclovir Resistance:** Most common in immunocompromised patients (e.g., HIV/AIDS) [1], [2].
Explanation: ### Explanation **Correct Option: D (Occipital neuralgia)** **Mechanism:** Herpes Zoster (Shingles) is caused by the reactivation of the **Varicella-Zoster Virus (VZV)** latent in the sensory ganglia [1]. While it most commonly affects thoracic dermatomes [1], it can involve the cervical spinal nerves. **Occipital neuralgia** occurs when the virus involves the **C2 and C3 nerve roots**, which give rise to the greater and lesser occipital nerves. The inflammation and subsequent nerve damage (post-herpetic neuralgia) lead to paroxysmal, lancinating pain in the posterior scalp and occipital region [1]. **Why Incorrect Options are Wrong:** * **Options A, B, and C (Lobe Infarctions):** While VZV is a known cause of **vasculopathy** (leading to stroke), it does not typically cause isolated "lobar" infarctions in a pattern specific to the frontal, parietal, or temporal lobes as a primary complication. VZV vasculopathy usually involves the **Middle Cerebral Artery (MCA)** territory or small penetrating vessels, leading to hemiplegia. However, in the context of this specific question, occipital neuralgia is a classic, direct sensory nerve complication of the infection. **High-Yield Clinical Pearls for NEET-PG:** * **Hutchinson’s Sign:** Vesicles on the tip of the nose indicate involvement of the nasociliary branch of the ophthalmic nerve (CN V1), predicting a high risk of **Herpes Zoster Ophthalmicus**. * **Ramsay Hunt Syndrome (Type II):** Reactivation in the **geniculate ganglion** (CN VII) leading to facial palsy, ear pain, and vesicles in the external auditory canal. * **Post-Herpetic Neuralgia (PHN):** Defined as pain persisting for >90 days after the rash heals [1]. First-line treatment includes **Gabapentin, Pregabalin, or Amitriptyline**. * **VZV Vasculopathy:** A unique cause of stroke in young patients or those with recent ophthalmic shingles; it results from the virus migrating along the trigeminal nerves to the cerebral arteries.
Explanation: ### Explanation **1. Why Option A is Correct:** The risk of developing **Pneumocystis jirovecii pneumonia (PCP)**—the most common opportunistic infection in HIV patients—increases significantly as the immune system weakens. Clinical guidelines (WHO and NACO) mandate primary prophylaxis with **Trimethoprim-Sulfamethoxazole (TMP-SMX)** when the CD4 T-lymphocyte count falls below **200 cells/mm³** or if the patient has a history of oropharyngeal candidiasis (a clinical marker of advanced immunosuppression) [1]. At this threshold, the host's cell-mediated immunity is insufficient to suppress the fungus, leading to life-threatening interstitial pneumonia. **2. Why Other Options are Incorrect:** * **Options B, C, and D:** While patients with CD4 counts between 200 and 500 cells/mm³ are immunocompromised, they generally maintain enough cellular immunity to prevent PCP [1]. Initiating prophylaxis at these higher levels is not recommended as it unnecessarily increases the risk of drug toxicity (e.g., Stevens-Johnson Syndrome) and antibiotic resistance. **3. NEET-PG Clinical Pearls & High-Yield Facts:** * **Drug of Choice:** TMP-SMX (Double strength tablet once daily). * **Alternative if allergic to Sulfa:** Dapsone or Atovaquone [1]. * **Discontinuation:** Prophylaxis can be safely stopped if the CD4 count rises above **>200 cells/mm³ for at least 3–6 months** in response to ART. * **Other CD4 Thresholds for Prophylaxis:** * **<100 cells/mm³:** Prophylaxis for *Toxoplasma gondii* (using TMP-SMX). * **<50 cells/mm³:** Prophylaxis for *Mycobacterium avium complex* (MAC) using Azithromycin (though guidelines now prioritize immediate ART over MAC prophylaxis). * **Radiology Tip:** Look for "ground-glass opacities" and "perihilar infiltrates" on a chest X-ray/CT [1].
Explanation: **Explanation:** **Correct Answer: A. Coronavirus** Severe Acute Respiratory Syndrome (SARS) is caused by the **SARS-associated coronavirus (SARS-CoV)**. Coronaviruses are large, enveloped, positive-sense single-stranded RNA (+ssRNA) viruses characterized by club-shaped surface projections (peplomers) that create a "halo" or crown-like appearance under electron microscopy. They primarily cause respiratory and enteric diseases. The SARS outbreak (2002–2004) originated in China and is zoonotic, with the **masked palm civet** and **bats** identified as key reservoirs. **Why other options are incorrect:** * **B. Picornavirus:** This family includes small, non-enveloped RNA viruses such as Poliovirus, Rhinovirus (common cold), and Hepatitis A. While Rhinoviruses cause respiratory symptoms, they do not cause SARS. * **C. Myxovirus:** This group includes Orthomyxoviruses (Influenza) and Paramyxoviruses (Measles, Mumps, RSV). While they cause significant respiratory pathology, their genomic structure and replication cycles differ from Coronaviridae. * **D. Retrovirus:** These are RNA viruses (like HIV) that use reverse transcriptase to integrate their genetic material into the host DNA. They are not associated with acute primary respiratory syndromes like SARS. **High-Yield Clinical Pearls for NEET-PG:** * **Receptor:** SARS-CoV and SARS-CoV-2 both utilize the **ACE-2 receptor** (Angiotensin-Converting Enzyme 2) found in the lungs, heart, and kidneys to enter host cells. * **MERS-CoV:** Another highly pathogenic coronavirus (Middle East Respiratory Syndrome) uses the **DPP-4 receptor**. * **Diagnosis:** Gold standard is **RT-PCR**. * **Imaging:** Characterized by "ground-glass opacities" on HRCT chest.
Explanation: Explanation: Neutropenia (absolute neutrophil count <1500/µL) is a common hematological manifestation of various viral infections. The underlying pathophysiology typically involves direct bone marrow suppression, the production of inhibitory cytokines (like IFN-γ), or the induction of anti-neutrophil antibodies. * **Hepatitis A:** While more commonly associated with transient leukopenia, Hepatitis A can cause bone marrow suppression. In rare but severe cases, it is a known trigger for **aplastic anemia**, which presents with profound neutropenia. * **Influenza A:** Acute viral respiratory infections, particularly Influenza, frequently cause a shift in neutrophil distribution (margination) and temporary marrow suppression, leading to a decrease in circulating neutrophils during the early phase of illness. * **HIV:** Neutropenia occurs in approximately 10–50% of HIV-infected individuals [1]. It results from direct infection of marrow stromal cells, secondary opportunistic infections (like CMV), or as a side effect of antiretroviral therapy (e.g., Zidovudine) [1]. **Clinical Pearls for NEET-PG:** 1. **Most common viral cause of neutropenia:** HIV and Cytomegalovirus (CMV) are high-yield associations [2]. 2. **Post-viral Neutropenia:** Usually occurs within the first 24–48 hours of infection and is typically transient. 3. **Differential Diagnosis:** Always consider **Epstein-Barr Virus (EBV)** and **Parvovirus B19** (which specifically targets erythroid precursors but can cause pancytopenia) when evaluating a patient with viral symptoms and low blood counts [1]. 4. **Drug-induced:** In PG exams, remember that **Ganciclovir** (used for CMV) and **Zidovudine** (AZT) are classic pharmacological causes of neutropenia in viral contexts [1].
Explanation: ### Explanation **Correct Option: A. p24 antigen** In the context of vertical transmission (mother-to-child), the gold standard for diagnosing HIV in infants under 18 months is **HIV DNA PCR** or **p24 antigen assay** [2]. The underlying medical concept is the **transplacental transfer of maternal IgG antibodies**. If a mother is HIV-positive, her antibodies will be present in the infant's blood for up to 18 months, regardless of whether the infant is actually infected. Therefore, tests that detect antibodies will yield a "false positive" result [1]. To confirm infection in a neonate, we must detect the virus itself (viral load/DNA) or its structural components, such as the **p24 capsid protein**, which appear before the host mounts an antibody response [2]. **Why other options are incorrect:** * **B. Serum ELISA:** This is a screening test that detects HIV antibodies [1]. In infants, it cannot differentiate between maternal antibodies and neonatal infection. * **C & D. Western Blot / Immunoblot:** These are confirmatory tests that detect specific antibodies against HIV proteins (like gp120, gp41). Like ELISA, they remain positive in infants due to maternal IgG, making them unreliable for diagnosing vertical transmission [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Window Period:** p24 antigen is the first marker to appear after infection (usually within 1–3 weeks), making it useful for early diagnosis before seroconversion. * **Best Initial Test for Infants (<18 months):** HIV DNA PCR (more sensitive than p24) [2]. * **Standard Screening (>18 months):** ELISA (4th generation tests now detect both p24 and antibodies). * **Confirmatory Test (Adults):** Western Blot (though newer algorithms favor Geenius™ HIV 1/2 supplemental assays) [1].
Cerebrovascular Diseases
Practice Questions
Seizure Disorders and Epilepsy
Practice Questions
Headache Disorders
Practice Questions
Movement Disorders
Practice Questions
Demyelinating Diseases
Practice Questions
Neurodegenerative Disorders
Practice Questions
Neuromuscular Junction Disorders
Practice Questions
Peripheral Neuropathies
Practice Questions
CNS Infections
Practice Questions
Neuro-oncology
Practice Questions
Dementia and Cognitive Disorders
Practice Questions
Neurological Emergencies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free